Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, May 2021

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 5 X posts from 2 X users, with an upper bound of 1,527 followers.

RT @JournalofExper1: Featured Review!🦋 #Superenhancers: a new frontier for epigenetic modifiers in cancer #chemoresistance Look here👇 htt…

Reply Repost Favourite

Featured Review!🦋 #Superenhancers: a new frontier for epigenetic modifiers in cancer #chemoresistance Look here👇 https://t.co/3tEVkmq5Nj #EpigeneticReprogramming #CancerTherapy https://t.co/Tmgu6Gc5mc

Reply Repost Favourite

RT @JournalofExper1: New Review! 🔎 𝐒𝐮𝐩𝐞𝐫-𝐞𝐧𝐡𝐚𝐧𝐜𝐞𝐫𝐬: 𝐚 𝐧𝐞𝐰 𝐟𝐫𝐨𝐧𝐭𝐢𝐞𝐫 𝐟𝐨𝐫 𝐞𝐩𝐢𝐠𝐞𝐧𝐞𝐭𝐢𝐜 𝐦𝐨𝐝𝐢𝐟𝐢𝐞𝐫𝐬 𝐢𝐧 𝐜𝐚𝐧𝐜𝐞𝐫 #𝐜𝐡𝐞𝐦𝐨𝐫𝐞𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞 View here 👇 https:…

Reply Repost Favourite

New Review! 🔎 𝐒𝐮𝐩𝐞𝐫-𝐞𝐧𝐡𝐚𝐧𝐜𝐞𝐫𝐬: 𝐚 𝐧𝐞𝐰 𝐟𝐫𝐨𝐧𝐭𝐢𝐞𝐫 𝐟𝐨𝐫 𝐞𝐩𝐢𝐠𝐞𝐧𝐞𝐭𝐢𝐜 𝐦𝐨𝐝𝐢𝐟𝐢𝐞𝐫𝐬 𝐢𝐧 𝐜𝐚𝐧𝐜𝐞𝐫 #𝐜𝐡𝐞𝐦𝐨𝐫𝐞𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞 View here 👇 https://t.co/3tEVkmq5Nj #EpigeneticReprogramming @IREISGufficiale https://t.co/HVP4OMBGO9

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.